News

Merck Foundation partners with African First Ladies and others to tackle diabetes and hypertension through education and ...
Researchers analyzed long-term survival of women diagnosed with low-risk cervical cancer, from 2010 through 2017, who ...
MSD has reported that the Phase III KEYNOTE-B96 trial of Keytruda plus paclitaxel, with or without bevacizumab, has met its ...
Press Release Redica Systems, a leader in Quality and Regulatory Intelligence for the Life Sciences industry, today announced a financing with participation by Merck Global Health Innovation Fund ...
Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.
We recently published a list of 13 Best Cheap Stocks to Invest in for Beginners. In this article, we are going to take a look ...
The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.
FDA Commissioner Marty Makary said Thursday that his agency is preparing to release a new regulatory framework within the ...
As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...
Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...
Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge economic investment for the company, and the small town.